Ann-Margret Ervin1,2, Harran Mkocha3, Beatriz Munoz1, Kurt Dreger1, Laura Dize4, Charlotte Gaydos4, Thomas C Quinn4,5, Sheila K West1. 1. a Dana Center for Preventive Ophthalmology, Wilmer Eye Institute , Johns Hopkins University , Baltimore , MD , USA. 2. b Department of Epidemiology , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA. 3. c Kongwa Trachoma Project , Kongwa , Tanzania. 4. d International Chlamydia Laboratory, Department of Medicine , Johns Hopkins University , Baltimore , MD , USA. 5. e National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda , MD , USA.
Abstract
PURPOSE: Immigrants and travelers may be sources of re-emergent infection in trachoma-endemic communities close to trachoma elimination. The primary objective of the A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) trial was to determine whether a newcomer and traveler surveillance and treatment program in addition to annual mass drug administration (MDA) would reduce Chlamydia trachomatis infection when compared to MDA alone. METHODS: ASANTE was a randomized controlled trial in 52 communities in Kongwa, Tanzania. In 26 intervention communities, monitors treated everyone in new households, in-coming children and guardians in existing households, and all persons in households who had traveled between annual MDA events. A total of 26 usual practice communities received MDA only. Surveys of 100 1-9-year-olds from each community were conducted at baseline and every 6 months up to 2 years to assess clinical trachoma and C. trachomatis infection. Data on demographics and environmental factors were also collected. RESULTS:Mean prevalences of trachomatous inflammation - follicular (TF) and C. trachomatis were equivalent between the two arms (5.2% and 3.7% in intervention, and 4.9% and 3.6% in usual practice communities, respectively). Of 318 children with TF, 36.5% tested positive for C. trachomatis. TF prevalence was higher among households without a bicycle (p = 0.03) and lower with increasing child's age (p < 0.001). Infection prevalence was higher among households >30 minutes from water (p = 0.015). TF and infection prevalence decreased with increasing years of education (p = 0.004 and p = 0.002, respectively). CONCLUSION: The ASANTE trial will inform guidance on the surveillance and treatment of persons traveling or newly arriving to communities hypo-endemic for trachoma.
RCT Entities:
PURPOSE: Immigrants and travelers may be sources of re-emergent infection in trachoma-endemic communities close to trachoma elimination. The primary objective of the A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) trial was to determine whether a newcomer and traveler surveillance and treatment program in addition to annual mass drug administration (MDA) would reduce Chlamydia trachomatis infection when compared to MDA alone. METHODS:ASANTE was a randomized controlled trial in 52 communities in Kongwa, Tanzania. In 26 intervention communities, monitors treated everyone in new households, in-coming children and guardians in existing households, and all persons in households who had traveled between annual MDA events. A total of 26 usual practice communities received MDA only. Surveys of 100 1-9-year-olds from each community were conducted at baseline and every 6 months up to 2 years to assess clinical trachoma and C. trachomatis infection. Data on demographics and environmental factors were also collected. RESULTS: Mean prevalences of trachomatous inflammation - follicular (TF) and C. trachomatis were equivalent between the two arms (5.2% and 3.7% in intervention, and 4.9% and 3.6% in usual practice communities, respectively). Of 318 children with TF, 36.5% tested positive for C. trachomatis. TF prevalence was higher among households without a bicycle (p = 0.03) and lower with increasing child's age (p < 0.001). Infection prevalence was higher among households >30 minutes from water (p = 0.015). TF and infection prevalence decreased with increasing years of education (p = 0.004 and p = 0.002, respectively). CONCLUSION: The ASANTE trial will inform guidance on the surveillance and treatment of persons traveling or newly arriving to communities hypo-endemic for trachoma.
Authors: Dianne Stare; Emma Harding-Esch; Beatriz Munoz; Robin Bailey; David Mabey; Martin Holland; Charlotte Gaydos; Sheila West Journal: Ophthalmic Epidemiol Date: 2011-02 Impact factor: 1.648
Authors: Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey Journal: N Engl J Med Date: 2004-11-04 Impact factor: 91.245
Authors: Neelima A Shah; Jenafir House; Takele Lakew; Wondu Alemayehu; Colleen Halfpenny; Kevin C Hong; Jeremy D Keenan; Travis C Porco; John P Whitcher; Thomas M Lietman; Bruce D Gaynor Journal: Ophthalmic Epidemiol Date: 2010-03 Impact factor: 1.648
Authors: Luis Carlos Cajas-Monson; Harran Mkocha; Beatriz Muñoz; Thomas C Quinn; Charlotte A Gaydos; Sheila K West Journal: PLoS Negl Trop Dis Date: 2011-03-15
Authors: Emma M Harding-Esch; Tansy Edwards; Harran Mkocha; Beatriz Munoz; Martin J Holland; Sarah E Burr; Ansumana Sillah; Charlotte A Gaydos; Dianne Stare; David C W Mabey; Robin L Bailey; Sheila K West Journal: PLoS Negl Trop Dis Date: 2010-11-02
Authors: Sheila K West; Beatriz Munoz; Harran Mkocha; Laura Dize; Charlotte A Gaydos; Bonnie Swenor; Ann-Margret Ervin; Thomas C Quinn Journal: PLoS One Date: 2017-06-29 Impact factor: 3.240
Authors: Xinyi Chen; Beatriz Munoz; Harran Mkocha; Charlotte A Gaydos; Laura Dize; Thomas C Quinn; Sheila K West Journal: PLoS Negl Trop Dis Date: 2022-07-13
Authors: Sheila K West; Beatriz Munoz; Hemjot Kaur; Laura Dize; Harran Mkocha; Charlotte A Gaydos; Thomas C Quinn Journal: Sci Rep Date: 2018-02-23 Impact factor: 4.379